Sentinel lymph node biopsy using methylene blue-fluorescein dye combination in post neo-adjuvant chemotherapy node negative (ycN0) breast cancer patients: A validation study
Current guidelines recommend dual-tracer sentinel lymph node biopsy in post neo-adjuvant chemotherapy node-negative (ycN0) breast cancer. Standard dual-tracer requires radiocolloid, which is often unavailable in low-to-middle-income countries. We evaluated a combination of methylene blue and fluorescein dyes as a low-cost alternative.
Authors
- Chandan Kumar Jha (ORCID: https://orcid.org/0000-0003-0968-3269)
- Upasna Sinha (ORCID: https://orcid.org/0000-0002-0915-3092)
- Tarun Kumar (ORCID: https://orcid.org/0000-0002-9078-2821)
- Mayank Mishra (ORCID: https://orcid.org/0009-0006-4560-3894)
- Prashant Kumar Singh
Institutions
- All India Institute of Medical Sciences, Patna (IN)
- All India Institute of Medical Sciences (IN)
Publication Details
- Journal
- Tropical Doctor
- Published
- 2026-11-05
- DOI
- https://doi.org/10.1177/00494755261503380
- Primary Topic
- Breast Cancer Treatment Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00